ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Expanded Criteria for HCC in Liver Transplantation.

M. Haberal,1 A. Akdur,1 G. Moray,1 G. Arslan,2 F. Ozcay,3 H. Selcuk,4 H. Ozdemir.5

1General Surgery and Transplantation, Baskent University, Ankara, Turkey
2Anesthesiology, Baskent University, Ankara, Turkey
3Pediatric Gastroenterology, Baskent University, Ankara, Turkey
4Gastroenterology, Baskent University, Ankara, Turkey
5Pathology, Baskent University, Ankara, Turkey

Meeting: 2017 American Transplant Congress

Abstract number: A85

Keywords: Hepatocellular carcinoma, Liver transplantation, Outcome

Session Information

Session Name: Poster Session A: Clinical Science: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies

Session Type: Poster Session

Date: Saturday, April 29, 2017

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall D1

Introduction: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third highest cause of death related to malignancy. Since HCC diagnosis is typically late, the median survival following diagnosis is approximately 6-20 months. The 5-year survival rate is reported as less than 12%. HCC typically arises in the background of cirrhosis. Liver transplantation is regarded as an optimal radical therapy for selected patients with HCC. Initial experiences with orthotopic liver transplantation were limited to patients with extensive unresectable tumors, and were marked by uniformly dismal outcomes due to high rates of tumor recurrence. We aimed to evaluate our LT indications and results for HCC.

Materials and Methods: Between 8 December 1988 and 01 October 2016 we performed 545 liver transplants at our centers. Since 1994 we use our criteria for LT in HCC candidates at Baskent University and currently perform LT in all HCC patients without major vascular invasion and distant metastasis. We retrospectively reviewed our LT results of patients with HCC.

Results: 61 patients had liver transplantation for HCC. 52 were male and 9 were female. 31 of the patients were operated according to our expended criteria. 6 of these patients were children and 25 were adults. We had 16 patients (1 pediatric and 15 adult) who were beyond Milan criteria radiologically and pathologically. We had 15 patients (4 pediatric and 11 adults) who were within Milan criteria radiologically; but after LT, when pathologic specimens were evaluated, they were found to be beyond Milan. We had 1 patient incidentally diagnosed after transplantation who was beyond Milan criteria. Disease free 5-year survival rate of LT patients beyond Milan criteria was 56.8%.

Conclusions: Milan criteria can be safely and effectively expanded with promising results even in patients beyond Milan criteria. Recently interventional radiology has being applied before transplantation or resection.

CITATION INFORMATION: Haberal M, Akdur A, Moray G, Arslan G, Ozcay F, Selcuk H, Ozdemir H. Expanded Criteria for HCC in Liver Transplantation. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Haberal M, Akdur A, Moray G, Arslan G, Ozcay F, Selcuk H, Ozdemir H. Expanded Criteria for HCC in Liver Transplantation. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/expanded-criteria-for-hcc-in-liver-transplantation/. Accessed May 14, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences